University of Miami/Sylvester Cancer Center
1475 NW 12 Avenue
Miami, FL 33136
Direct phone: (305) 243-6447
Total transplants by cell source
- Marrow: 14
- PBSC: 146
- Cord Blood: 0
- Autologous (PBSC or Marrow): 259
About the center
The University of Miami Sylvester Cancer Center is an NCI Designated Cancer Center. The Adult Stem Cell Transplant Program was founded in 1992 and is FACT accredited. The program provides comprehensive, multidisciplinary care for patients requiring autologous and allogeneic stem cell transplants and immune effector cell therapies. This care is provided in an academic environment with inpatient and outpatient facilities optimized for the care of stem cell therapy recipients.
This center has been performing allogeneic transplants since 1994 and has been an NMDP/Be The Match transplant center since December 2001.
Adult - Amer Beitinjaneh, Mark Goodman, Antonio Jimenez, Krishna Komanduri, Lazaros Lekakis, Denise Pereira, Trent Wang
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
Discounts with local hotels. Patients and caregivers are required to attend one of our monthly Meet and Greet Meetings which is run by a multidisciplinary team to provide information regarding transplant and allow future patients to meet some of our former patients. This class is available in English and Spanish and at one of our satellite clinics in Broward County.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 262 patients.
The actual 1-year survival of these patients is 72.1%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 66.1% and 76.6%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)